Market Whales and Their Recent Bets on BMY Options
Portfolio Pulse from Benzinga Insights
Financial giants have shown a bullish interest in Bristol-Myers Squibb (BMY) through options trading, with 40% of traders being bullish. The stock is currently trading at $48.87, up by 1.31%. Analysts have mixed ratings, with price targets ranging from $41 to $53.
August 27, 2024 | 6:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bristol-Myers Squibb sees bullish interest from financial giants in options trading, with 40% of traders bullish. The stock is up 1.31% at $48.87. Analysts have mixed ratings, with price targets between $41 and $53.
The bullish interest in BMY options suggests positive sentiment among financial giants, which could drive the stock price up. The current stock price increase of 1.31% supports this. However, mixed analyst ratings introduce some uncertainty.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100